Genpharmasec share news and announcements

BSE: 531592Commercial Services & SuppliesSmall Cap

₹0.99₹0.03 (2.94%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹1.02.

52-week range of traded prices to 23 Oct 2026

₹0.75Low, 30 Mar 2026₹1.84High, 27 Oct 2025

Market cap: ₹55 Cr3,222nd largest listed
P/E: Earlier quarters restated in the year
P/B: 0.8
Dividend yield: Nonein the last 12 months
ROCE: −1.4%
Debt to equity: 0.50
Volume, BSE: 4,22,891

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Genpharmasec quarterly results

Aug11Tue

The board met on 11 Aug 2026 to consider quarterly results

Notice filed 3 Aug 2026

Genpharmasec annual reports, presentations and earnings calls

The company's own documents, latest first.Genpharmasec financials, year by year

Annual reports20

Annual report, year to Mar 2026 (opens in a new tab)7 Sep 2026
Annual report, year to Mar 2025 (opens in a new tab)5 Sep 2025
Annual report, year to Mar 2024 (opens in a new tab)11 Jul 2024
Annual report, year to Mar 2023 (opens in a new tab)1 Sep 2023
Annual report, year to Mar 2022 (opens in a new tab)6 Sep 2022

15 earlier reports

Annual report, year to Mar 2021 (opens in a new tab)6 Sep 2021
Annual report, year to Mar 2020 (opens in a new tab)28 Nov 2020
Annual report, year to Mar 2019 (opens in a new tab)3 Sep 2019
Annual report, year to Mar 2018 (opens in a new tab)16 Oct 2018
Annual report, year to Mar 2017 (opens in a new tab)6 Oct 2017
Annual report, year to Mar 2016 (opens in a new tab)13 Oct 2016
Annual report, year to Mar 2015 (opens in a new tab)9 Sep 2015
Annual report, year to Mar 2014 (opens in a new tab)31 Jan 2015
Annual report, year to Mar 2013 (opens in a new tab)7 Oct 2013
Annual report, year to Mar 2012 (opens in a new tab)25 Apr 2013
Annual report, year to Mar 2011 (opens in a new tab)15 May 2012
Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
Annual report, year to Mar 1997 (opens in a new tab)Filing day not known

Investor presentations1

Generic Pharmasec Enters Medical & Diagnostic Devices Segment with Abbot India Ltd. (opens in a new tab)26 Mar 2019

Genpharmasec share news and announcements

609 announcements, routine notices left out, newest first. Page 1 of 13.

Oct 2026
- 14 Oct · Intimation Regarding Change Of Name Of Subsidiary Of The Company
  Intimation under regulation 30 - Change of name of Subsidiary of the company. (opens in a new tab)
Sep 2026
Aug 2026
- 31 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Sadhwani (opens in a new tab)
- 28 Aug · Board meeting
  Meeting on 2 Sep 2026: annual general meeting
- 28 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve 1. To Fix the Day, Date, Time .... (opens in a new tab)
- 13 Aug · Business
  Regarding Recent Agreement with Amneal Healthcare Private Limited (opens in a new tab)
- 11 Aug · Business
  Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026. (opens in a new tab)
- 11 Aug · Results
  Unaudited Standalone & Consolidated Financial Results of the company for the quarter ended 30th June, 2026. (opens in a new tab)
- 11 Aug · Results
  Outcome of the Meeting of Board of Directors held on Tuesday, 11th August, 2026. (opens in a new tab)
- 3 Aug · Board meeting
  Meeting on 11 Aug 2026: quarterly results
- 3 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... (opens in a new tab)
May 2026
- 21 May · Business
  Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st March, 2026. (opens in a new tab)
- 21 May · Results
  Audited Standalone & Consolidated Financial Results of the company for the Quarter and Financial year Ended 31st March, 2026. (opens in a new tab)
- 21 May · Results
  Outcome of the Meeting of Board of Directors held on Thursday, May 21, 2026. (opens in a new tab)
- 13 May · Board meeting
  Meeting on 21 May 2026: audited results
- 13 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. To consider, approve & take .... (opens in a new tab)
Mar 2026
- 24 Mar · Outcome Of Separate Meeting Of Independent Directors Of The Company.
  Outcome of Separate Meeting of Independent Directors held on March 24, 2026. (opens in a new tab)
Feb 2026
- 9 Feb · Business
  Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st December, 2025. (opens in a new tab)
- 9 Feb · Results
  Unaudited Standalone & Consolidated Financial Result of the company for the quarter ended December 31, 2025. (opens in a new tab)
- 9 Feb · Results
  Outcome of the Meeting of Board of Directors held on Monday, February 09, 2026. (opens in a new tab)
- 2 Feb · Board meeting
  Meeting on 9 Feb 2026: quarterly results
- 2 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve Unaudited .... (opens in a new tab)
Nov 2025
Oct 2025
- 27 Oct · Board meeting
  Meeting on 6 Nov 2025: quarterly results
- 27 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... (opens in a new tab)
Sep 2025
Aug 2025
- 28 Aug · Board meeting
  Meeting on 2 Sep 2025: annual general meeting
- 28 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and approve 1. To Fix the Day, Date, Time .... (opens in a new tab)
- 7 Aug · Business
  Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2025. (opens in a new tab)
- 7 Aug · Results
  Unaudited Standalone & Consolidated Financial Results of the company for the quarter ended 30th June, 2025. (opens in a new tab)
- 7 Aug · Results
  Outcome of the Meeting of Board of Directors held on Thursday, 07th August, 2025. (opens in a new tab)
- 1 Aug · Board meeting
  Meeting on 7 Aug 2025: quarterly results
- 1 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... (opens in a new tab)
Jul 2025
- 25 Jul · Business
  Update on acquisition of 70% stake in Derren Healthcare Private Limited. (opens in a new tab)
May 2025
- 21 May · Business
  Statement of Deviation or variation in the use of proceeds of Right issue for the quarter ended 31st March, 2025. (opens in a new tab)
- 21 May · Results
  Audited Standalone & Consolidated Financial Results of the company for the quarter and financial year ended 31st March, 2025. (opens in a new tab)

How the price met the news

The first session after each announcement, beside the market.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

3 Sep 2026Board or managers changed0.00%−0.1 pts vs Nifty 500market median 0.0% · five sessions −9.7% (−8.5 pts vs Nifty 500) · volume 1.2× usual · The announcement (opens in a new tab)
21 Mar 2024Board or managers changeddown 1.68%−3.0 pts vs Nifty 500market median 0.0% · five sessions −6.3% (−9.5 pts vs Nifty 500) · volume 2.3× usual · The announcement (opens in a new tab)
13 Mar 2024Board or managers changeddown 4.81%−2.2 pts vs Nifty 500market median 0.0% · five sessions −21.6% (−18.9 pts vs Nifty 500) · volume 4.7× usual · The announcement (opens in a new tab)
12 Oct 2022Board or managers changeddown 0.21%−0.9 pts vs Nifty 500market median 0.0% · five sessions +3.9% (+1.7 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
11 Oct 2022Board or managers changedup 0.41%+2.0 pts vs Nifty 500market median 0.0% · five sessions +7.1% (+7.4 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
6 Oct 2022Board or managers changedup 1.00%+0.4 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−2.1 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
16 Sep 2022Board or managers changeddown 2.84%−0.7 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−3.9 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
22 Jun 2022Board or managers changeddown 0.65%+0.8 pts vs Nifty 500market median 0.0% · five sessions +10.0% (+8.3 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
20 Jun 2022Board or managers changeddown 7.10%−6.8 pts vs Nifty 500market median 0.0% · five sessions +15.7% (+13.2 pts vs Nifty 500) · volume 1.5× usual · The announcement (opens in a new tab)
7 Sep 2021Board or managers changeddown 0.62%−0.5 pts vs Nifty 500market median 0.0% · five sessions +0.5% (−0.2 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)

4 earlier announcements

16 Aug 2021Board or managers changeddown 1.04%−1.1 pts vs Nifty 500market median 0.0% · five sessions −8.7% (−7.8 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
30 Jun 2021Board or managers changedup 0.23%+0.3 pts vs Nifty 500market median 0.0% · five sessions +9.8% (+9.1 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
3 Mar 2020Board or managers changed0.00%+2.7 pts vs Nifty 500market median 0.0% · five sessions −10.9% (+6.6 pts vs Nifty 500) · volume 0.0× usual · The announcement (opens in a new tab)
3 Jun 2019Board or managers changeddown 4.96%−6.1 pts vs Nifty 500market median 0.0% · five sessions −10.5% (−10.4 pts vs Nifty 500) · volume 0.0× usual · The announcement (opens in a new tab)

Sharp moves

The latest 30. 19 of the 30 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

7 Sep 20263 filingsdown 9.60%−9.2 pts vs Nifty 5003.7× its usual move · volume 1.0× usual
31 Aug 20261 filingup 9.71%+10.0 pts vs Nifty 5004.5× its usual move · volume 9.5× usual
2 Apr 2026No filing that day or the nextup 15.05%+15.0 pts vs Nifty 5003.3× its usual move · volume 1.2× usual
1 Apr 2026No filing that day or the nextup 19.23%+17.2 pts vs Nifty 5005.1× its usual move · volume 1.0× usual
27 Feb 2026No filing that day or the nextdown 9.23%−8.0 pts vs Nifty 5003.0× its usual move · volume 1.0× usual
30 Oct 2025No filing that day or the nextdown 6.18%−5.7 pts vs Nifty 5003.5× its usual move · volume 5.0× usual
7 Oct 20251 filingdown 4.81%−5.0 pts vs Nifty 5003.1× its usual move · volume 1.8× usual
19 Sep 2025No filing that day or the nextup 6.19%+6.3 pts vs Nifty 5004.8× its usual move · volume 3.4× usual
18 Aug 2025No filing that day or the nextup 4.64%+3.5 pts vs Nifty 5003.9× its usual move · volume 1.2× usual
9 Dec 20241 filingup 9.78%+9.9 pts vs Nifty 5003.1× its usual move · volume 3.6× usual

20 earlier moves

6 Dec 2024No filing that day or the nextup 9.82%+9.7 pts vs Nifty 5003.4× its usual move · volume 7.0× usual
23 Aug 2024No filing that day or the nextup 9.71%+9.8 pts vs Nifty 5003.5× its usual move · volume 1.4× usual
22 Aug 2024No filing that day or the nextup 9.88%+9.6 pts vs Nifty 5003.9× its usual move · volume 1.0× usual
21 Aug 2024No filing that day or the nextup 10.00%+9.6 pts vs Nifty 5004.6× its usual move · volume 7.7× usual
5 Jan 20241 filingup 19.64%+19.4 pts vs Nifty 5004.7× its usual move · volume 14.1× usual
4 Jan 2024No filing that day or the nextup 19.93%+19.0 pts vs Nifty 5005.9× its usual move · volume 14.8× usual
3 Jan 20242 filingsup 15.48%+15.7 pts vs Nifty 5005.6× its usual move · volume 6.4× usual
15 Nov 2023No filing that day or the nextup 15.98%+14.9 pts vs Nifty 5005.8× its usual move · volume 9.8× usual
4 Sep 2023No filing that day or the nextup 8.33%+7.7 pts vs Nifty 5003.8× its usual move · volume 6.6× usual
5 Jun 20233 filingsup 19.87%+19.6 pts vs Nifty 5005.9× its usual move · volume 7.9× usual
5 Apr 20232 filingsup 13.25%+12.5 pts vs Nifty 5005.0× its usual move · volume 3.2× usual
31 Mar 20232 filingsup 12.27%+10.8 pts vs Nifty 5006.0× its usual move · volume 1.5× usual
23 Mar 2023No filing that day or the nextdown 7.42%−7.0 pts vs Nifty 5004.5× its usual move · volume 3.5× usual
27 Feb 2023No filing that day or the nextdown 6.19%−5.6 pts vs Nifty 5003.6× its usual move · volume 3.2× usual
3 Oct 20221 filingup 19.77%+21.1 pts vs Nifty 5007.6× its usual move · volume 8.4× usual
24 Jun 2022No filing that day or the nextup 9.57%+8.5 pts vs Nifty 5003.1× its usual move · volume 4.7× usual
2 Jun 2022No filing that day or the nextup 9.96%+9.4 pts vs Nifty 5004.7× its usual move · volume 1.7× usual
11 Jan 20221 filingup 20.00%+19.8 pts vs Nifty 5003.8× its usual move · volume 3.3× usual
10 Jan 2022No filing that day or the nextup 20.00%+19.0 pts vs Nifty 5004.4× its usual move · volume 3.8× usual
4 Jan 2022No filing that day or the nextup 15.73%+15.0 pts vs Nifty 5003.9× its usual move · volume 5.0× usual

Figures filed again

Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.

Line	Period	Accounts	First filed	Filed again		First filed on	Filed again on
Revenue from operations	Quarter to Jun 2024	Consolidated	5.19	5.20	0.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Other income	Quarter to Jun 2024	Consolidated	0.57	0.57	−0.2%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Total income	Quarter to Jun 2024	Consolidated	5.76	5.76	0.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Employee costs	Quarter to Jun 2024	Consolidated	0.18	0.18	0.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Finance costs	Quarter to Jun 2024	Consolidated	0.10	0.10	0.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Depreciation and amortisation	Quarter to Jun 2024	Consolidated	0.16	0.16	0.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Other expenses	Quarter to Jun 2024	Consolidated	0.69	0.65	−5.3%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Total expenses	Quarter to Jun 2024	Consolidated	5.27	5.25	−0.4%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Profit before tax	Quarter to Jun 2024	Consolidated	0.49	0.51	+4.7%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Tax	Quarter to Jun 2024	Consolidated	0.20	0.18	−9.5%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Net profit	Quarter to Jun 2024	Consolidated	0.29	0.33	+14.6%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Goods bought for resale	Quarter to Jun 2024	Consolidated	5.67	5.33	−6.1%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Change in stock held	Quarter to Jun 2024	Consolidated	−1.52	−1.52	0.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Profit before one-off items and tax	Quarter to Jun 2024	Consolidated	0.49	0.51	+4.7%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Deferred tax	Quarter to Jun 2024	Consolidated	0.20	0.18	−9.5%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Net profit from continuing businesses	Quarter to Jun 2024	Consolidated	0.29	0.33	+14.6%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Total comprehensive income	Quarter to Jun 2024	Consolidated	0.51	0.55	+8.2%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Segment revenue	Quarter to Jun 2024	Consolidated	5.34	5.19	−2.7%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Segment profit before tax and finance costs	Quarter to Jun 2024	Consolidated	0.59	0.62	+4.0%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Segment finance costs	Quarter to Jun 2024	Consolidated	0.11	0.11	+0.1%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)
Segment profit before tax	Quarter to Jun 2024	Consolidated	0.49	0.51	+4.7%	17 Sep 2024 (opens in a new tab)	12 Nov 2024 (opens in a new tab)

Last results date

Genpharmasec annual reports, presentations and earnings calls

Annual reports20

Investor presentations1

Genpharmasec share news and announcements

Oct 2026

Sep 2026

Aug 2026

May 2026

Mar 2026

Feb 2026

Nov 2025

Oct 2025

Sep 2025

Aug 2025

Jul 2025

May 2025

How the price met the news

Sharp moves

Figures filed again